TrialRegenerative medicine2025

Results from the SCIENCE and Danish ASC trials using allogeneic mesenchymal stromal cells to treat ischemic heart failure patients.

Nadia Chaaban et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.